GlassScriptPhysician profile
Rosemary Ayerle
NPI 1720088560
$4,288.49
in general payments reported to CMS, 2019-2025
28 companies · $701 in 2025
The $701 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.19 · 2022: $1,301 · 2023: $1,172 · 2024: $1,079 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $832.84 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $551.22 | 2022-2025 | |
| Lilly USA, LLC | $503.21 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $430.57 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $288.65 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $270.59 | 2022-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $184.50 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.96 | 2022-2024 | Jardiance, Tradjenta |
| Abbott Laboratories | $152.52 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| E.R. Squibb & Sons, L.L.C. | $124.39 | 2022-2025 | Eliquis, Camzyos |
| Amgen INC. | $114.11 | 2023-2025 | Evenity, Prolia, Repatha |
| Merck Sharp & Dohme LLC | $112.54 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Kowa Pharmaceuticals America, INC. | $81.70 | 2022-2025 | Seglentis, Livalo, Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $75.23 | 2022 | |
| Dexcom, INC. | $70.99 | 2024-2025 | Dexcom G6 Transmitter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $44.95 | 2023 | Intellis Adaptivestim |
| Dynavax Technologies Corporation | $43.40 | 2023 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $36.19 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $35.51 | 2024 | |
| Vbi Vaccine (Delaware) INC. | $27.28 | 2022 | |
| Axsome Therapeutics, INC. | $24.17 | 2025 | Auvelity |
| Horizon Therapeutics Plc | $23.27 | 2022 | |
| Quidel Corporation | $20.00 | 2021 | |
| Boston Scientific Corporation | $17.72 | 2022 | |
| Ani Pharmaceuticals, INC. | $16.15 | 2024 | Purified Cortrophin Gel |
| Sumitomo Pharma America, INC. | $16.13 | 2024 | Gemtesa |
| Hikma Pharmaceuticals USA | $15.79 | 2023 | Ryaltris |
| Astellas Pharma US INC | $13.91 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosemary Ayerle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.